Post by Merz Therapeutics

After many years of dedicated leadership at Merz Therapeutics, Martin Künzel will retire at the end of June 2026. We extend our sincere gratitude for his long-standing commitment and the strong foundation he has built in Switzerland. Following this leadership transition, Alexander Zach will assume responsibility for Switzerland in addition to his current role in Austria. This step will ensure continuity and further strengthen collaboration across both markets.   We thank Alexander for taking on this additional responsibility and look forward to supporting him in his new role.   We extend our best wishes to Martin for the future.   #MerzTherapeutics #LeadershipUpdate #BetterOutcomesForMorePatients